Ceapro Inc.
CRPOF · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $3 | $2 | $3 | $2 |
| % Growth | 68% | -37% | 40.1% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $1 |
| Gross Profit | $1 | $0 | $1 | $1 |
| % Margin | 38.3% | 5.9% | 41.2% | 57.3% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $4 | $3 | $3 | $3 |
| Operating Income | -$2 | -$3 | -$2 | -$2 |
| % Margin | -88.3% | -168% | -58.1% | -81.7% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$2 | -$3 | -$1 | -$1 |
| Tax Expense | -$1 | -$0 | -$0 | -$0 |
| Net Income | -$2 | -$2 | -$1 | -$1 |
| % Margin | -68.1% | -129% | -39.7% | -61.8% |
| EPS | -0.024 | -0.027 | -0.013 | -0.015 |
| % Growth | 11.4% | -104.5% | 10.1% | – |
| EPS Diluted | -0.024 | -0.027 | -0.013 | -0.015 |
| Weighted Avg Shares Out | 78 | 78 | 78 | 78 |
| Weighted Avg Shares Out Dil | 78 | 78 | 78 | 78 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$2 | -$1 | -$1 |
| % Margin | -69.7% | -127.2% | -34% | -48.1% |